FHTX Financials
Foghorn Therapeutics Inc - Financial statements & key metrics
Stock Price
$5.57
Market Cap
$237.79M
P/E Ratio
-3.5
EPS
$-1.14
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$22.60M
Gross Profit
-
Operating Income
-
Net Income
$-86.62M
EPS (Diluted)
$-1.58
Balance Sheet Highlights
Total Assets
$283.98M
Total Liabilities
$329.51M
Shareholders Equity
-
Cash & Equivalents
$55.45M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-100.41M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-226.9%
Net Margin
-294.2%
ROE
-470.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is FHTX revenue?
FHTX's most recent quarterly revenue was $22.60M. Annual revenue can be calculated by summing the four most recent quarters.
Is FHTX profitable?
FHTX reported a loss of $86.62M in the most recent quarter. The net profit margin is -294.2%.
What is FHTX market cap?
FHTX has a market capitalization of $237.79M, making it a small-cap stock.
Does FHTX have debt?
View FHTX's balance sheet for debt information.
What is FHTX cash flow?
Cash flow data is available in the full financial statements.